January 29, 2026

Asana, Inc. (ASAN) Stock Analysis: Can This Work Management Platform Unlock a 43% Upside?

Asana, Inc. (NYSE: ASAN), a prominent player in the technology sector’s software application industry, offers a compelling opportunity for investors looking to tap into the burgeoning..

Pacific Biosciences of California (PACB) Stock Analysis: Navigating Growth Potential Amidst Market Challenges

Pacific Biosciences of California, Inc. (NASDAQ: PACB), a key player in the healthcare sector, operates within the medical devices industry, specializing in advanced sequencing technologies. With..

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Biotech with 355% Potential Upside

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT), a burgeoning player in the biotechnology sector, is capturing investor attention with its cutting-edge developments in mRNA-based therapeutics. Based in..

NetClass Technology Inc (NTCL) Stock Analysis: Navigating Volatility with a Market Cap of $8.72 Million

NetClass Technology Inc (NTCL) is a software application company that operates within the dynamic technology sector, focusing on online professional education platforms. Despite being incorporated only..

CytomX Therapeutics, Inc. (CTMX) Stock Analysis: Biotech Innovator with 44% Potential Upside

Investors with an eye on the biotechnology sector might find CytomX Therapeutics, Inc. (NASDAQ: CTMX) an intriguing opportunity. With a market capitalization just shy of $1..

Shopify Inc. (SHOP) Stock Analysis: Is a 29% Potential Upside Worth the Investment?

Shopify Inc. (NYSE: SHOP), a titan in the e-commerce technology landscape, is generating buzz among investors with a substantial potential upside of 29.20%. As the company..

Varex Imaging Corporation (VREX) Stock Analysis: Uncovering a 23% Upside Potential in the Medical Devices Sector

Varex Imaging Corporation (NASDAQ: VREX) stands out in the healthcare sector as a key player in the medical devices industry, with a market capitalization of $586.03..

SANUWAVE Health, Inc. (SNWV) Stock Analysis: Uncovering a 104% Potential Upside in the Medical Device Sector

SANUWAVE Health, Inc. (SNWV), a burgeoning player in the healthcare sector, is making waves in the medical device industry with its innovative approach to regenerative medicine...

Gossamer Bio, Inc. (GOSS) Stock Analysis: Uncovering a Potential 269.75% Upside in Biotech Innovation

Gossamer Bio, Inc. (NASDAQ: GOSS) has captured the attention of investors with its ambitious focus on developing groundbreaking treatments in the biotechnology sector. Headquartered in San..

Tvardi Therapeutics, Inc. (TVRD) Stock Analysis: Exploring a 113% Potential Upside in Biotech Innovation

Tvardi Therapeutics, Inc. (NASDAQ: TVRD), a clinical-stage biopharmaceutical company based in Sugar Land, Texas, is making waves in the biotechnology industry with its promising pipeline of..

Alumis Inc. (ALMS) Stock Analysis: A Biotech Contender with a 34.43% Potential Upside

Alumis Inc. (NASDAQ: ALMS), a burgeoning player in the biotechnology sector, is grabbing investor attention with its promising pipeline focused on autoimmune disorders. Based in South..

XOMA Royalty Corporation (XOMA) Stock Analysis: A Biotech Gem with 161.56% Potential Upside

For investors with a penchant for biotechnology stocks, XOMA Royalty Corporation (NASDAQ: XOMA) presents an intriguing opportunity. With a robust market capitalization of $305.37 million and..

Quantum-Si Incorporated (QSI): Investor Outlook on a Potential 123% Upside in the Medical Devices Sector

For investors with a keen eye on the healthcare sector, Quantum-Si Incorporated (NASDAQ: QSI) presents a compelling case for consideration. Operating within the innovative medical devices..

Nano-X Imaging Ltd (NNOX) Stock Analysis: Exploring a 170% Upside Potential in the Healthcare Sector

As investors continue to navigate the dynamic landscape of healthcare technology, Nano-X Imaging Ltd (NASDAQ: NNOX) emerges as a noteworthy contender with a compelling potential upside..

Phathom Pharmaceuticals, Inc. (PHAT) Stock Analysis: Exploring a 65% Potential Upside in the Biotech Arena

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) stands as a compelling case within the biotechnology sector, presenting individual investors with intriguing prospects. With a market capitalization of $1.08..

Canopy Growth Corporation (CGC) Stock Analysis: Is a 61% Upside on the Horizon?

For investors keeping an eye on burgeoning sectors, Canopy Growth Corporation (NASDAQ: CGC) presents a fascinating case study in the dynamic cannabis industry. While the company..

Vanda Pharmaceuticals Inc. (VNDA): Investor Outlook Reveals 77% Potential Upside

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is making waves in the biotechnology sector with a promising pipeline and an impressive potential upside of 77.18%, according to recent..

Nyxoah SA (NYXH) Stock Report: Exploring the 135% Potential Upside in Sleep Apnea Solutions

For investors seeking intriguing opportunities in the medical technology sector, Nyxoah SA (NASDAQ: NYXH) presents a compelling case. This Belgium-based company, with a market capitalization of..

Exxon Mobil Corporation (XOM) Stock Analysis: Navigating Market Dynamics with a $586 Billion Giant

Exxon Mobil Corporation (NYSE: XOM), a titan in the energy sector, continues to attract investor attention with its robust market presence and strategic initiatives in the..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring a 61% Potential Upside Opportunity

Entrada Therapeutics, Inc. (NASDAQ: TRDA), with its strategic focus on innovative biotechnology solutions, presents a compelling case for investors, particularly given its notable 61.43% potential upside..

Search

Funds

January 29, 2026

Search

Funds

January 29, 2026

FTSE 100

Funds